etofylline clofibrate has been researched along with clofibrate in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 19 (65.52) | 18.7374 |
| 1990's | 10 (34.48) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kłosiewicz-Latoszek, L; Szostak, WB | 1 |
| Hirst, DG | 1 |
| Ceska, R; Kvasilová, M; Procházková, R; Sobra, J | 1 |
| Hirst, DG; Wood, PJ | 1 |
| Balonová, T; Bencová, E; Durisová, M; Horáková, M; Nosál, R; Onderová, E; Ujházy, E; Zeljenková, D | 1 |
| Cleland, ME; McCraw, AP; Metz, G; Sim, AK | 1 |
| Augustin, J; Gnasso, A; Haberbosch, W; Ziegler, W | 1 |
| Scherhag, R | 1 |
| Fiegel, G | 1 |
| Metz, G; Specker, M | 1 |
| Lücker, PW; Ritschel, WA; Thompson, GA; Wetzelsberger, K | 1 |
| Korn, WD; Sterner, W | 1 |
| Ginocchio, AV; Metz, G | 1 |
| Davies, JE; Kellett, DN | 1 |
| Chibanguza, G; Metz, G; Sterner, W | 1 |
| Davies, ME; McCraw, AP; Metz, G; Sim, AK | 1 |
| Donike, M; Erking, W; Lücker, PW; Wetzelsberger, K | 1 |
| Metz, G; Specker, M; Ziegler, WJ | 1 |
| Hausmann, L; Mühlfellner, G; Mühlfellner, O; Schneider, J; Schubotz, R | 1 |
| Ditschuneit, H; Ditschuneit, HH; Hutt, V; Klör, HU | 1 |
| Vorberg, G; Ziegler, WJ | 1 |
| Ziegler, WJ | 1 |
| Chmela, Z; Hrbková, M; Hrebícek, J; Skottová, N | 1 |
| Hucková, M; Raslová, K | 1 |
| Haas, T; Hilgertová, J; Justová, V; Sindelka, G; Skrha, J | 1 |
| Ceska, R; Justová, V; Jůzová, Z; Kvasilová, M; Procházková, R; Sobra, J; Wilczek, H | 1 |
| Ceska, R; Sobra, J; Toschnerová, H; Traurig, J | 1 |
| Klimes, I; Langrová, H; Linke-Cvrkalová, A; Pleváková, L; Rajecová, E; Rychnavská, E; Seböková, E | 1 |
| Föger, B; Hopferwieser, T; Lechleitner, M; Menzel, HJ; Patsch, JR; Pfeiffer, KP; Ritsch, A; Tröbinger, G; Utermann, G | 1 |
4 trial(s) available for etofylline clofibrate and clofibrate
| Article | Year |
|---|---|
[Therapeutic effect of etofyllinclofibrate in disordered lipid and uric acid metabolism].
Topics: Adult; Aged; Cholesterol; Cholesterol, HDL; Clinical Trials as Topic; Clofibrate; Female; Humans; Hyperlipoproteinemias; Hypolipidemic Agents; Lipoproteins, HDL; Male; Metabolic Diseases; Middle Aged; Uric Acid | 1982 |
[Effect of etofylline clofibrate on the composition of lipoproteins in hyperlipidaemia type IIb and IV (author's transl)].
Topics: Adult; Aged; Clofibrate; Female; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type IV; Hypolipidemic Agents; Lipoproteins; Male; Middle Aged | 1980 |
[Therapeutic experiences in the treatment of hyperlipoproteinaemia with etofylline clofibrate (author's transl)].
Topics: Clofibrate; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type IV; Hyperlipoproteinemias; Hypolipidemic Agents | 1980 |
[On the uricosuric activity of etofylline clofibrate (author's transl)].
Topics: Clofibrate; Humans; Hypolipidemic Agents; Uric Acid; Uricosuric Agents | 1980 |
25 other study(ies) available for etofylline clofibrate and clofibrate
| Article | Year |
|---|---|
Comparative studies on the influence of different fibrates on serum lipoproteins in endogenous hyperlipoproteinaemia.
Topics: Adult; Aged; Bezafibrate; Cholesterol; Clofibrate; Clofibric Acid; Colestipol; Female; Fenofibrate; Gemfibrozil; Humans; Hyperlipoproteinemias; Hypolipidemic Agents; Lipoproteins; Male; Middle Aged; Probucol | 1991 |
Tumour radiosensitization by clofibrate and its analogs: possible mechanisms.
Topics: Animals; Bezafibrate; Clofibrate; Combined Modality Therapy; Etanidazole; Female; Hypoxia; Mice; Mice, Inbred C3H; Neoplasms, Experimental; Nitroimidazoles; Oxygen; Radiation-Sensitizing Agents; Regional Blood Flow | 1990 |
[Etolip and Lipanthyl in the treatment of hyperlipoproteinemia].
Topics: Clofibrate; Female; Fenofibrate; Humans; Hyperlipoproteinemias; Hypolipidemic Agents; Male; Middle Aged; Propionates | 1990 |
Chlorophenoxy acetic acid derivatives as hemoglobin modifiers and tumor radiosensitizers.
Topics: Animals; Clofibrate; Female; Mice; Mice, Inbred C3H; Neoplasms, Experimental; Oxyhemoglobins; Radiation-Sensitizing Agents | 1989 |
Teratological study of the hypolipidaemic drugs etofylline clofibrate (VULM) and fenofibrate in Swiss mice.
Topics: Animals; Body Weight; Clofibrate; Female; Fenofibrate; Fetus; Gestational Age; Hypolipidemic Agents; Mice; Organ Size; Pregnancy; Propionates; Teratogens | 1989 |
Effect of etofylline clofibrate on experimental thrombus formation and prostacyclin activation.
Topics: Animals; Biotransformation; Clofibrate; Cricetinae; Epoprostenol; Fibrinolytic Agents; Hypolipidemic Agents; Male; Mesocricetus | 1986 |
The effect of etophylline clofibrate on HDL subfractions.
Topics: Adult; Aged; Apolipoproteins; Cholesterol, LDL; Clofibrate; Female; Heparin; Humans; Hyperlipoproteinemia Type II; Lipolysis; Lipoproteins, HDL; Lipoproteins, HDL2; Lipoproteins, HDL3; Male; Middle Aged; Ultracentrifugation | 1985 |
[Modification of serum uric acid concentration under long-term therapy with the lipid-regulating drug Duolip].
Topics: Clofibrate; Humans; Hyperlipidemias; Hypolipidemic Agents; Time Factors; Uric Acid | 1983 |
[Chemistry of phenoxyacetic acid esters of oxyalkyltheophyllines and 1-(theophyllin-7-yl)-ethyl-2-[2-(p-chlorophenoxy)-2-methyl-propionate] (etofylline clofibrate), a novel antilipaemic agent (author's transl)].
Topics: Chemical Phenomena; Chemistry; Clofibrate; Esterification; Humans; Hypolipidemic Agents | 1980 |
Biopharmaceutic evaluation of etofylline clofibrate and its drug formulation.
Topics: Biopharmaceutics; Capsules; Clofibrate; Humans; Hypolipidemic Agents; Particle Size; Powders; Solubility | 1980 |
[Pharmacology and toxicology of etofylline clofibrate].
Topics: Animals; Clofibrate; Dogs; Female; Hypolipidemic Agents; Male; Mice; Motor Activity; Pregnancy; Rats; Reproduction; Species Specificity; Teratogens; Time Factors | 1980 |
Hypolipaemic activity of 1-(theophyllin-7-yl)-ethyl-2-[2-(p-chlorophenoxy)-2-methylpropionate] (etofylline clofibrate) and its analogues in normolipaemic rats.
Topics: Animals; Cholesterol; Clofibrate; Dose-Response Relationship, Drug; Hypolipidemic Agents; Lipids; Male; Rats; Triglycerides | 1980 |
Evaluation of the hypolipaemic activity of etofylline clofibrate, a new ester of etofylline and clofibric acid, and comparison with effects of known hypolipaemic agents.
Topics: Animals; Cholesterol; Clofibrate; Diet; Female; Hypolipidemic Agents; Rats; Triglycerides | 1980 |
[Evaluation of the antilipaemic potential of etofylline clofibrate, its metabolites and clofibrate in dietary-induced hyperlipidaemia in the rat (author's transl)].
Topics: Animals; Body Weight; Clofibrate; Diet; Hyperlipidemias; Hypolipidemic Agents; Lipids; Male; Rats | 1980 |
Effect of etofylline clofibrate on experimental thrombosis and platelet function.
Topics: Animals; Blood Platelets; Clofibrate; Cricetinae; Female; Hypolipidemic Agents; In Vitro Techniques; Macaca fascicularis; Male; Platelet Adhesiveness; Platelet Aggregation; Thrombosis | 1980 |
[Metabolism and pharmacokinetics of etofylline clofibrate, new antilipemic].
Topics: Animals; Clofibrate; Dogs; Hypolipidemic Agents; Intestinal Absorption; Intestinal Mucosa; Kinetics; Lipase; Rats; Species Specificity | 1980 |
[Clinical effects and tolerance of etofylline clofibrate].
Topics: Clofibrate; Humans; Hyperlipidemias; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type III; Hyperlipoproteinemia Type IV; Hypolipidemic Agents | 1980 |
[On the effect of etofylline clofibrate on serum lipids and lipoproteins in patients with hyperlipoproteinemia of various degrees (author's transl)].
Topics: Cholesterol; Clofibrate; Humans; Hyperlipoproteinemias; Hypolipidemic Agents; Lipids; Lipoproteins; Triglycerides; Uric Acid | 1980 |
[Use of etofyllinclofibrate (Duolip Forte) in combined hyperlipidemia].
Topics: Adult; Aged; Clofibrate; Female; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type V; Hypolipidemic Agents; Lipids; Male; Middle Aged | 1995 |
[Etophylline clofibrate in the treatment of familial combined hyperlipoproteinemia].
Topics: Apolipoproteins B; Blood Glucose; Clofibrate; Female; Humans; Hyperlipidemia, Familial Combined; Hypolipidemic Agents; Male | 1995 |
[Relation between hypertriacylglycerolemia and the action of insulin in type 2 diabetes mellitus].
Topics: Adult; Aged; Clofibrate; Diabetes Mellitus, Type 2; Female; Fenofibrate; Humans; Hypertriglyceridemia; Hypolipidemic Agents; Insulin Resistance; Male; Middle Aged | 1994 |
[Therapy with fibrates and vitamin D metabolism].
Topics: Adult; Clofibrate; Female; Fenofibrate; Humans; Hyperlipoproteinemias; Hypolipidemic Agents; Male; Middle Aged; Vitamin D | 1993 |
[Duolip Forte--experience during a 6-month period of administration].
Topics: Adult; Aged; Clofibrate; Female; Humans; Hyperlipoproteinemias; Hypolipidemic Agents; Male; Middle Aged | 1993 |
[Etofylline clofibrate in the treatment of diabetic dyslipidemia: results of a 6-month period of therapy].
Topics: Clofibrate; Diabetes Mellitus, Type 2; Female; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type IV; Hypolipidemic Agents; Male; Middle Aged | 1995 |
Treatment of primary mixed hyperlipidemia with etophylline clofibrate: effects on lipoprotein-modifying enzymes, postprandial lipoprotein metabolism, and lipoprotein distribution and composition.
Topics: Carrier Proteins; Cholesterol Ester Transfer Proteins; Chylomicrons; Clofibrate; Eating; Female; Glycoproteins; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipase; Lipoprotein(a); Lipoproteins; Male; Middle Aged; Transaminases; Triglycerides; Vitamin A | 1995 |